John Geigert – författare
Visar alla böcker från författaren John Geigert. Handla med fri frakt och snabb leverans.
14 produkter
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Inbunden, 2026
2026 kr
Lägg i varukorg
CMC regulatory compliance strategy for biopharmaceuticals has become vastly more complex and challenging in the past couple of years, especially as the number of gene therapies have entered development and even market approval. Biopharmaceuticals today can be either protein-based or gene-based. For …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Inbunden, 2003
2010 kr
Lägg i varukorg
"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
E-bok, 2012
2948 kr
Lägg i varukorg
"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Häftad, 2012
2250 kr
Lägg i varukorg
"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Inbunden, 2013
2811 kr
Lägg i varukorg
This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
E-bok, 2014
2599 kr
Lägg i varukorg
This book highlights the challenges facing quality assurance/quality control (QA/QC) in today''s biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Häftad, 2016
2026 kr
Lägg i varukorg
This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Inbunden, 2019
1799 kr
Lägg i varukorg
Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
E-bok, 2019
2267 kr
Lägg i varukorg
Biopharmaceuticals (i.e., biological medicines sourced from genetically-engineered living systems) for treatment of human diseases have become a significant percentage of the pharmaceutical industry. And not just the recombinant DNA-derived proteins and monoclonal antibodies (both from the …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
E-bok, 2023
2341 kr
Lägg i varukorg
Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Häftad, 2024
1875 kr
Lägg i varukorg
Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
E-bok, 2026
2110 kr
Lägg i varukorg
CMC regulatory compliance strategy for biopharmaceuticals has become vastly more complex and challenging in the past couple of years, especially as the number of gene therapies have entered development and even market approval. Biopharmaceuticals today can be either protein-based or gene-based. For …
Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
Inbunden, 2023
2478 kr
Tillfälligt slut
Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion …
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Av John Geigert
2023
686 kr
Tillfälligt slut